Advertisement
Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc. (MIRM) Stock Overview

Explore Mirum Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

MIRM●NASDAQ
HealthcareBiotechnology
$92.49
$0.66(0.71%)
U.S. Market opens in 16h 7m
Advertisement

Mirum Pharmaceuticals, Inc. (MIRM)

Meyka AI Score

Z

Key Financials

Market Cap4.6B
P/E Ratio-6.75
EPS (TTM)$-13.60
ROE-2.89%
Fundamental Analysis

AI Price Forecasts

1 Month$87.29
3 Months$104.57
1 Year Target$119.58

MIRM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Mirum Pharmaceuticals, Inc. (MIRM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.29, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $119.58.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -6.75 and a market capitalization of 4.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.71%
5-Day Change
-7.25%
1-Month Change
-12.57%
3-Month Change
-0.59%
6-Month Change
29.30%
Year-to-Date (YTD) Change
17.09%
1-Year Change
107.33%
3-Year Change
243.45%
5-Year Change
447.93%
All-Time (Max) Change
600.15%

Contact Information

https://www.mirumpharma.com
650 667 4085
950 Tower Lane, Foster City, CA, 94404

Company Facts

334 Employees
IPO DateJul 18, 2019
CountryUS
Actively Trading

Frequently Asked Questions